The glymphatic system flushes out waste products from the brain – now scientists have found a way to boost it in mice, which ...

and perhaps lead to early imaging biomarkers [of the disease] (...)." "Assuming that the effects of alpha-synuclein in the mouse brain and in the human brain are similar, which I think is a ...

The FDA approved a test that can help clinicians diagnose Alzheimer's disease early on using a simple blood draw. The test detects signs of amyloid plaque build-up in the brain.

The U.S. Food and Drug Administration cleared the first in vitro diagnostic device that tests blood to aid in diagnosing ...

The FDA cleared the first blood test on Friday to help diagnose Alzheimer's disease among older Americans already exhibiting ...

Dr. Richard G. Stefanacci explains why the FDA's recent clearance of a diagnostic blood test for Alzheimer's deserves ...

The blood test is nearly 92% as accurate as a PET scan or spinal tap ... which are believed to be hallmarks of Alzheimer’s disease. Alzheimer's is a degenerative brain disease that is caused ...

found in human plasma. These proteins indicate the presence of harmful plaques that form between brain nerve cells and disrupt normal brain function. Alzheimer’s disease develops over many years ...

The blood test was cleared for use in people age 55 and older who exhibit signs and symptoms of the disease. The FDA said ...

A ratio of those proteins tends to correlate with the occurrence or absence of amyloid plaques in the brain, which are among the hallmarks of Alzheimer’s disease ... their PET scan or ...

The first in vitro diagnostic device that uses blood samples to detect Alzheimer disease has been granted marketing clearance by the US Food and Drug Administration.